Moret, E.
Ambresin, A.
Gianniou, C.
Bijon, J.
Besse-Hayat, C.
Bogiatzi, S.
Hohl, D.
Spertini, F.
Mantel, I.
Funding for this research was provided by:
University of Lausanne
Article History
Received: 16 March 2021
Revised: 21 July 2021
Accepted: 27 July 2021
First Online: 16 September 2021
Change Date: 14 February 2022
Change Type: Update
Change Details: Open access funding provided by University of Lausanne has been added as funding.
Declarations
:
: The authors have no conflicts of interest to declare that are relevant to the content of this article. Irmela Mantel is an occasional consultant to Novartis, Bayer, and Roche.
: This retrospective study was performed in accordance with the tenets of the ethical standards of the Ethics Committee of the Swiss Federal Department of Health (no. CER-VD 19/15 and 20/15), the 1964 Declaration of Helsinki, and its later amendments, and was by the Ethics Committee of the Swiss Federal Department of Health for retrospective data analysis.approved.
: The need for consent was waived by the ethics committee.